Keywords: Gilead Sciences, AIDS, HIV, Elvitegravir, Complera, Cobicistat

Batch of clinical trial results for Gilead's elvitegravir, Complera and cobicistat

Article | 25 July 2012

Print This

US biotech firm Gilead Sciences (Nasdaq: GILD), the world’s biggest producer of HIV treatments, announced a batch of ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in